☆ 4.5 Article

Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Immunology

SARS-CoV-2 infections in children: Understanding diverse outcomes

Petter Brodin

Summary: SARS-CoV-2 infections in children usually result in mild or asymptomatic infections, and the reasons behind this are not fully understood. Possible explanations include more efficient local tissue responses, better thymic function, and crossreactive immunity. Post-infectious hyperinflammatory syndromes are rare in children and young people, but very rarely seen in adults. This article offers an additional explanation to mild infections, viral dynamics, and the higher incidence of rare multisystem inflammatory syndromes in children and young people from a life history and energy allocation perspective.

IMMUNITY (2022)

添加到收藏夹

Letter Medicine, General & Internal

Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France

Michael Levy et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Editorial Material Immunology

An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2

Audrey Dionne et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021

Laura D. Zambrano et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

添加到收藏夹

Article Immunology

Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis

Magali Noval Rivas et al.

Summary: Multisystem inflammatory syndrome in children (MIS-C) is a febrile pediatric inflammatory disease that may develop in relation to SARS-CoV-2 infection. MIS-C is characterized by systemic hyperinflammation and multiorgan involvement, with similarities to Kawasaki disease and toxic shock syndrome. Molecular analysis and immunosequencing studies have revealed the presence of SAg-like and neurotoxin-like structures in MIS-C, which may contribute to autoimmune responses and neurological symptoms.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain

Cinta Moraleda et al.

Summary: Clusters of children with MIS-C associated with SARS-CoV-2 infection have been reported in Spain. MIS-C is a potentially severe condition that presents in children with recent SARS-CoV-2 infection.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Pediatrics

Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults A Systematic Review and Meta-analysis

Russell M. Viner et al.

Summary: This systematic review and meta-analysis found that children and adolescents have a 44% lower odds of secondary infection with SARS-CoV-2 compared to adults, with insufficient data to determine if children transmit the virus less than adults. Preliminary evidence suggests that children have a lower susceptibility to SARS-CoV-2 infection compared with adults, but their role in virus transmission remains unclear.

JAMA PEDIATRICS (2021)

添加到收藏夹

Review Pediatrics

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process

Rachel Harwood et al.

Summary: PIMS-TS is a newly discovered condition associated with COVID-19, and a national consensus management pathway has been developed for UK clinicians caring for affected children. The guidance emphasizes the importance of a multidisciplinary team in decision-making and recommends treatment options including supportive care, immunoglobulin, steroids, and biological therapies. This guidance provides a solid framework for clinicians caring for children with PIMS-TS in the UK and will be updated based on future evidence.

LANCET CHILD & ADOLESCENT HEALTH (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19

Supriya Ravichandran et al.

Summary: The study identified SARS-CoV-2 antibody signatures in children associated with disease severity, providing insights for potential serodiagnostic and virus neutralization targets in the future.

NATURE IMMUNOLOGY (2021)

添加到收藏夹

Review Rheumatology

Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison

Chetan Sharma et al.

Summary: Children and adolescents infected with SARS-CoV-2 often exhibit mild symptoms, but may also develop a pediatric systemic vasculitis called MIS-C. This condition shares features with myocarditis and Kawasaki disease. Research indicates that MIS-C is a result of an exaggerated immune response triggered by prior exposure to SARS-CoV-2.

NATURE REVIEWS RHEUMATOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19

Leora R. Feldstein et al.

Summary: Comparing the clinical characteristics and outcomes of patients with MIS-C and COVID-19 can help distinguish between the two conditions and improve health outcomes. Patterns of clinical presentation and organ system involvement were identified in this case series, providing valuable information for differentiation of MIS-C and COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Letter Medicine, General & Internal

Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons

Stephen M. Kissler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Pediatrics

Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study

Fernanda Lima-Setta et al.

Summary: This study described the clinical, laboratory, and radiological characteristics of children with MIS-C, and found that most patients had similar features to other cohorts. Long-term multidisciplinary follow-up is needed to observe if chronic cardiac impairment or other sequelae may occur in these patients.

JORNAL DE PEDIATRIA (2021)

添加到收藏夹

Article Pediatrics

Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis

Ulla Koskela et al.

Summary: The study found a decrease in Kawasaki disease cases and a low occurrence rate of MIS-C during the COVID-19 pandemic. The reduced incidence of respiratory infections and the protective effect of social distancing suggest a potential link between transmissible microbes and Kawasaki disease.

ACTA PAEDIATRICA (2021)

添加到收藏夹

Article Medicine, General & Internal

Treatment of Multisystem Inflammatory Syndrome in Children

Andrew J. McArdle et al.

Summary: This international observational cohort study found no significant difference in the recovery from MIS-C after primary treatment with IVIG alone, IVIG plus glucocorticoids, or glucocorticoids alone, although significant differences may emerge as more data accrue.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Pediatrics

Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children

Kanwal M. Farooqi et al.

Summary: In this study, 45 children with MIS-C were followed longitudinally, with the majority presenting critically ill on admission but showing rapid resolution of inflammatory and cardiac manifestations. While most inflammatory markers normalized by 1 to 4 weeks postdischarge, some children exhibited persistent lymphocytosis and elevated levels of double-negative T cells at later follow-up points. Ultimately, only a small proportion of children had persistent echocardiographic abnormalities at 4 to 9 months postdischarge.

PEDIATRICS (2021)

添加到收藏夹

Article Pediatrics

Schools as a Framework for COVID-19 Epidemiological Surveillance of Children in Catalonia, Spain: A Population-Based Study

Aida Perramon et al.

Summary: A study on childhood COVID-19 incidence in Catalonia, Spain, found that despite significant diagnostic efforts among children, their relative incidence was slightly lower than for the general population and increased with age. Additionally, children had a lower positivity rate for SARS-CoV-2 compared to adults.

FRONTIERS IN PEDIATRICS (2021)

添加到收藏夹

Review Pediatrics

Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland

Luregn J. Schlapbach et al.

Summary: In the absence of high-grade evidence, best practice guidelines for the diagnosis and treatment of children with suspected PIMS-TS were developed in Switzerland. These recommendations are based on currently available knowledge and aim to standardize treatment. Regular updates of the recommendations will be necessary due to the rapidly changing field and the need for more evidence.

FRONTIERS IN PEDIATRICS (2021)

添加到收藏夹

Article Medicine, General & Internal

Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2

Amanda B. Payne et al.

Summary: In this study, it was found that Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare complication associated with SARS-CoV-2 infection, with higher incidence rates among Black, Hispanic or Latino, and Asian or Pacific Islander individuals. Further research is needed to explore the variations by race/ethnicity and age group.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier

Lael M. Yonker et al.

Summary: In children with MIS-C, prolonged presence of SARS-CoV-2 in the GI tract led to the release of zonulin, a biomarker of intestinal permeability, and subsequent trafficking of SARS-CoV-2 antigens into the bloodstream, resulting in hyperinflammation. Treatment with larazotide, a zonulin antagonist, reduced plasma SARS-CoV-2 spike antigen levels and inflammatory markers in a patient with MIS-C, leading to clinical improvement beyond current available treatments. These mechanistic insights provide potential targets for diagnosing, treating, and preventing MIS-C in children.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in US Children and Adolescents

Leora R. Feldstein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in Children in New York State

Elizabeth M. Dufort et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Infectious Diseases

COVID-19 in children: current evidence and key questions

Alasdair P. S. Munro et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2020)

添加到收藏夹

Review Pediatrics

Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome

Danilo Buonsenso et al.

FRONTIERS IN PEDIATRICS (2020)

添加到收藏夹

Article Critical Care Medicine

Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain

Alberto Garcia-Salido et al.

CRITICAL CARE (2020)

添加到收藏夹

Review Infectious Diseases

COVID-19 and multisystem inflammatory syndrome in children and adolescents

Li Jiang et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells

Sunhee Lee et al.

EMERGING MICROBES & INFECTIONS (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.